PNXGF (Standard Life) Research & Development: $0 Mil (TTM As of Dec. 2025)


PNXGF Standard Life PLC PNXGF
57 GF Score
Price $10.10
GF Value $13.71
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Standard Life Research & Development?

Standard Life PNXGF -0.25% 57 Research & Development is $0 Mil as of Dec. 2025. GuruFocus rates PNXGF with a GF Score™ of 57/100 and a GF Value™ of $13.71 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Standard Life's Research & Development for the six months ended in Dec. 2025 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $0 Mil.

Standard Life  (OTCPK:PNXGF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Standard Life Research & Development Related Terms

Standard Life Research & Development Historical Data

* Premium members only.

The historical data trend for Standard Life's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Standard Life Research & Development Chart

Standard Life Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Standard Life Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
PNXGF
57GF Score
Standard Life PLC PNXGF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Standard Life Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0 Mil mean?
Standard Life (PNXGF) has a Research & Development of $0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Standard Life and its competitors.
Is Standard Life's Research & Development too high?
Standard Life's current Research & Development is $0 Mil. Overall, Standard Life has a GF Score™ of 57/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Standard Life's Research & Development compare to AFL and MET?
Standard Life's Research & Development of $0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Standard Life and its competitors. Standard Life's current Research & Development is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Standard Life stock overvalued right now?
Based on GuruFocus' analysis, Standard Life (PNXGF) is currently considered Modestly Undervalued. The stock's GF Value™ is $13.71, compared to a current price of $10.10 — trading 26.3% below its estimated fair value. The current Research & Development is $0 Mil. Standard Life's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Standard Life (PNXGF), the current Research & Development is $0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Standard Life (PNXGF) Overvalued in 2026?

Based on GuruFocus' analysis, Standard Life stock appears to be undervalued. The current stock price of $10.10 is trading 26.3% below its estimated GF Value™ of $13.71. GuruFocus considers Standard Life to be Modestly Undervalued.

Key valuation signals for PNXGF:

  • Research & Development: $0 Mil
  • GF Value™: $13.71 vs. price of $10.10 (26.3% below fair value)
  • GF Score™: 57/100 with 4 warning signs

No single metric tells the full story. See the PNXGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Standard Life Business Description

Other Exchanges SDLFl:UKSDLF:UK36P:Germany
Address 20 Old Bailey, London, GBR, EC4M 7AN
Standard Life PLC provides financial products and services related to savings and retirement planning. It serves customers directly, through financial advisers, and through employer-sponsored pension schemes.
57GF Score

Get the complete analysis for PNXGF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.10
Price
$13.71
GF Value